TFA Therapeutics, Inc. (RAJAF) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.19M | +3.9% |
| 2024 | $5.00M | +42.7% |
| 2023 | $3.50M | +14.6% |
| 2022 | $3.06M | -13.6% |
| 2021 | $3.54M | +24.7% |
| 2020 | $2.84M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.19M | +3.9% |
| 2024 | $5.00M | +42.7% |
| 2023 | $3.50M | +14.6% |
| 2022 | $3.06M | -13.6% |
| 2021 | $3.54M | +24.7% |
| 2020 | $2.84M | — |